"Vasoconstriction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE.
| Descriptor ID |
D014661
|
| MeSH Number(s) |
G09.330.380.925
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vasoconstriction".
Below are MeSH descriptors whose meaning is more specific than "Vasoconstriction".
This graph shows the total number of publications written about "Vasoconstriction" by people in this website by year, and whether "Vasoconstriction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2006 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 0 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vasoconstriction" by people in Profiles.
-
Inhibition of CYP450 pathways reduces functional sympatholysis in healthy young adults. Am J Physiol Regul Integr Comp Physiol. 2025 Jun 01; 328(6):R642-R650.
-
Prevention of hypertension-induced renal vascular dysfunction through a p66Shc-targeted mechanism. Am J Physiol Renal Physiol. 2025 May 01; 328(5):F693-F701.
-
Reversible Cerebral Vasoconstriction Syndrome Associated With Fluoxetine. J Acad Consult Liaison Psychiatry. 2021 Nov-Dec; 62(6):634-644.
-
Stellate ganglion block used to treat reversible cerebral vasoconstriction syndrome. Reg Anesth Pain Med. 2021 08; 46(8):732-734.
-
Prostaglandin E2, a postulated mediator of neurovascular coupling, at low concentrations dilates whereas at higher concentrations constricts human cerebral parenchymal arterioles. Prostaglandins Other Lipid Mediat. 2020 02; 146:106389.
-
Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome. J Am Heart Assoc. 2018 04 04; 7(8).
-
Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017 Jul 01; 19(7):1211-1219.
-
Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis. Atherosclerosis. 2016 08; 251:226-233.
-
Pharmacotherapy of Vasospastic Angina. J Cardiovasc Pharmacol Ther. 2016 09; 21(5):439-51.
-
AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction. Hypertension. 2015 Oct; 66(4):830-5.